Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjunct to Fluoxetine in MDD
NCT04088448Phase 2Completed
- Sponsor
- Sadat City University
- Start
- Jan 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in major depressive disorder (MDD), sponsored by Sadat City University. Started Jan 2017; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04088448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088448.